文献速递其他结缔组织病

超声引导下腮腺粗针穿刺活检在干燥综合征中的应用

Ultrasound-guided core needle biopsy of the parotid gland in Sjögren's disease: a promising tool towards precision medicine.
PubMed 文献 · RMD Open · 2025-10-23

在比利时干燥综合征过渡试验中,66例患者(64例无腺体肿胀)接受超声引导下腮腺粗针穿刺活检(US-guided CNB)。活检期间平均疼痛VAS评分为2.7(SD=2.77),第14天随访前3天平均为1.9(SD=2.33);无重大并发症,82%患者愿意重复操作,62/66例获得足够组织。组织学严重程度与超声评分相关(p<0.01),与传统结局指标无关。

要点

  • US-guided CNB在干燥综合征患者中安全、耐受良好且能获取足够组织。
  • 82%患者愿意重复操作,活检期间平均疼痛VAS为2.7(SD=2.77)。
  • 组织学严重程度与超声评分相关(p<0.01),与传统结局指标无关。

核心结论

  • US-guided CNB安全、耐受良好且能获取足够组织,可能有助于组织学驱动的患者分层和干燥综合征精准医学。

研究设计与样本

  • 比利时干燥综合征过渡试验中,66例患者(64例无腺体肿胀)接受超声引导下腮腺粗针穿刺活检,超声采用OMERACT和Hocevar评分评估,组织病理评估包括灶性评分、B细胞优势(CD20>CD3)、滤泡树突状细胞网络(CD21)、浆细胞(CD138)、淋巴上皮病变(CK7/CK14)和FcRL4+ B细胞,疼痛采用0-10视觉模拟量表(VAS)评估,结果与临床数据匹配。

主要发现

  • 活检期间平均疼痛VAS评分为2.7(SD=2.77),第14天随访电话前3天平均为1.9(SD=2.33)。
  • 无重大并发症发生,82%患者愿意重复操作。
  • 62/66例获得足够组织。
  • 患者呈现组织学异质性,作为概念验证被分层为轻度、中度和重度组织学受累。
  • 组织学严重程度与超声评分相关(p<0.01),与传统结局指标(EULAR Sjögren's Syndrome Patient-Reported Index干燥评分和EULAR Sjögren's Syndrome Disease Activity Index)无关。

关键数值与推荐

  • 活检期间平均疼痛VAS评分2.7(SD=2.77),第14天随访前3天平均1.9(SD=2.33)。
  • 82%患者愿意重复操作。
  • 62/66例获得足够组织。
  • 组织学严重程度与超声评分相关(p<0.01)。

临床怎么用

  • US-guided CNB可用于干燥综合征患者的腮腺组织取样,安全且耐受良好,可能促进组织学驱动的分层。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Disappointing outcomes in Sjögren's disease (SjD) trials underscore the need for reliable, sensitive endpoints. Histological assessment holds promise, but a minimally invasive, repeatable method for salivary gland tissue sampling is lacking. OBJECTIVES: To evaluate the feasibility, safety and tissue adequacy of ultrasound-guided core needle biopsy (US-guided CNB) of the parotid gland and explore its role for facilitating histology-driven stratification and precision medicine. METHODS: In the Belgian Sjögren's Syndrome Transition Trial, 66 patients (64 without gland swelling) underwent US-guided CNB. US was evaluated using OMERACT (Outcome Measures in Rheumatology Clinical Trials). and Hocevar scoring. Histopathology included assessment of focus score, B cell predominance (CD20>CD3), follicular dendritic cell networks (CD21), plasma cells (CD138), lymphoepithelial lesions (CK7/CK14) and FcRL4+ B cells. Pain was assessed using a visual analogue scale (VAS) from 0 to 10. Findings were matched with clinical data. RESULTS: Mean VAS pain scores were 2.7 (SD=2.77) during biopsy and 1.9 (SD=2.33) in the 3 days before the follow-up call at day 14. No major complications occurred, and 82% of patients were willing to repeat the procedure. Adequate tissue was retrieved in 62/66 cases. Patients showed histological heterogeneity and were, as proof of concept, stratified into mild, moderate and severe histological involvement. Histological severity correlated with ultrasound scores (p<0.01) and not with traditional outcome measures (European Alliance of Associations for Rheumatology Sjögren's Syndrome Patient-Reported Index dryness and European Alliance of Associations for Rheumatology Sjögren's Syndrome Disease Activity Index). CONCLUSION: US-guided CNB is safe, well-tolerated and yields adequate tissue. Beyond diagnostics, it might facilitate histology-driven patient stratification and advance precision medicine for SjD.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Achten H, Genbrugge E, Deroo L, et al. Ultrasound-guided core needle biopsy of the parotid gland in Sjögren's disease: a promising tool towards precision medicine. RMD Open. 2025. PMID: 41136222. doi:10.1136/rmdopen-2025-005560

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。